Skip to main content
. Author manuscript; available in PMC: 2022 Sep 11.
Published in final edited form as: Expert Opin Ther Targets. 2021 Sep 11;25(8):645–658. doi: 10.1080/14728222.2021.1976142

Figure 2.

Figure 2.

Promising drug targets from experimental studies. Multiple signaling pathways are involved in the hepatocarcinogenesis, among which the HGF/MET, FGF/FGFR, PI3K/AKT/mTOR, and CDK4/6 signaling pathways hold the promises as effective targets for HCC treatment. Targeted drugs showing efficacious anti-tumor effects from the preclinical studies are shown and summarized in the figure. Normal arrows: activation; blunted arrows: inhibition.